- C-TERMINAL SRC KINASE INHIBITORS
-
Provided herein are novel C-terminal Srk Kinase (CSK) inhibitors, e.g., having Formula G, I, II, or III. Also provided are methods of preparing the novel CSK inhibitors and method of using the novel CSK inhibitors for treating diseases or disorder such as cancer or for promoting immune response in a subject in need thereof. (G)
- -
-
Paragraph 156; 157
(2020/07/14)
-
- Compounds for kinase modulation, and indications therefor
-
Compounds active on protein kinases and methods for regulating protein kinase pathways are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
- -
-
Paragraph 0639; 0640
(2016/10/07)
-
- BENZENE SULFONAMIDE THIAZOLE AND OXAZOLE COMPOUNDS
-
The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
- -
-
Page/Page column 89
(2011/06/16)
-
- Benzene Sulfonamide Thiazole and Oxazole Compounds
-
The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
- -
-
Page/Page column 55-56
(2009/12/23)
-